Antiviral Res

1. MOON C, Porges E, Roberts A, Bacon J, et al
   A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication.
   Antiviral Res. 2024 Mar 14:105859. doi: 10.1016/j.antiviral.2024.105859.
   

   >> Share

   
   

   
   Clin Infect Dis

2. COYLE RP, Morrow M, Mann SC, Mainella V, et al
   Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons with HIV Receiving Tenofovir Alafenamide and Emtricitabine-based Antiretroviral Therapy (QUANTI-TAF).
   Clin Infect Dis. 2024 Apr 18:ciae212. doi: 10.1093.
   

   >> Share

   
   

   
   J Infect Dis

3. BEGRE L, Boyd A, Plissonnier ML, Testoni B, et al
   Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
   J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093.
   

   >> Share

   
   

   
   Proc Natl Acad Sci U S A

4. PAPINI C, Ullah I, Ranjan AP, Zhang S, et al
   Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.
   Proc Natl Acad Sci U S A. 2024;121:e2320713121.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share